Mark E Saad - Net Worth and Insider Trading
Mark E Saad Net Worth
The estimated net worth of Mark E Saad is at least $893,207 dollars as of 2024-12-28. Mark E Saad is the Director of Axsome Therapeutics Inc and owns about 10,302 shares of Axsome Therapeutics Inc (AXSM) stock worth over $893,183. Mark E Saad is also the CFO of Plus Therapeutics Inc and owns about 20 shares of Plus Therapeutics Inc (PSTV) stock worth over $23. Details can be seen in Mark E Saad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark E Saad has not made any transactions after 2024-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark E Saad
Mark E Saad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark E Saad owns 3 companies in total, including Catheter Precision Inc (VTAK) , Axsome Therapeutics Inc (AXSM) , and Plus Therapeutics Inc (PSTV) .
Click here to see the complete history of Mark E Saad’s form 4 insider trades.
Insider Ownership Summary of Mark E Saad
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VTAK | Catheter Precision Inc | 2018-09-26 | director |
| AXSM | Axsome Therapeutics Inc | 2024-09-11 | director |
| PSTV | Plus Therapeutics Inc | 2012-03-14 | Chief Financial Officer |
Mark E Saad Latest Holdings Summary
Mark E Saad currently owns a total of 2 stocks. Among these stocks, Mark E Saad owns 10,302 shares of Axsome Therapeutics Inc (AXSM) as of September 11, 2024, with a value of $893,183 and a weighting of 100%. Mark E Saad also owns 20 shares of Plus Therapeutics Inc (PSTV) as of March 14, 2012, with a value of $23 and a weighting of 0%.
Latest Holdings of Mark E Saad
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | 2024-09-11 | 10,302 | 86.70 | 893,183 |
| PSTV | Plus Therapeutics Inc | 2012-03-14 | 20 | 1.16 | 23 |
Holding Weightings of Mark E Saad
Mark E Saad Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark E Saad has made a total of 2 transactions in Axsome Therapeutics Inc (AXSM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Axsome Therapeutics Inc is the sale of 11,016 shares on September 11, 2024, which brought Mark E Saad around $1 Million.
According to the SEC Form 4 filings, Mark E Saad has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 1 shares on March 14, 2012, which cost Mark E Saad around $25,500.
Insider Trading History of Mark E Saad
- 1
Mark E Saad Trading Performance
GuruFocus tracks the stock performance after each of Mark E Saad's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark E Saad is -12.22%. GuruFocus also compares Mark E Saad's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark E Saad within 3 months outperforms 2 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark E Saad's insider trading performs compared to the benchmark.
Performance of Mark E Saad
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.63 | | | | | |
| Relative Return to S&P 500(%) | -5.65 | | | | | |
Mark E Saad Ownership Network
Mark E Saad Owned Company Details
What does Catheter Precision Inc do?
Who are the key executives at Catheter Precision Inc?
Mark E Saad is the director of Catheter Precision Inc. Other key executives at Catheter Precision Inc include director & Executive Chairman of Board David A Jenkins , Chief Financial Officer Steven K Passey , and Chief Financial Officer Brian Conn .
Catheter Precision Inc (VTAK) Insider Trades Summary
Over the past 18 months, Mark E Saad made no insider transaction in Catheter Precision Inc (VTAK). Other recent insider transactions involving Catheter Precision Inc (VTAK) include a net purchase of 52,259 shares made by David A Jenkins ,
In summary, during the past 3 months, insiders sold 0 shares of Catheter Precision Inc (VTAK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catheter Precision Inc (VTAK) were sold and 5,226 shares were bought by its insiders, resulting in a net purchase of 5,226 shares.
Catheter Precision Inc (VTAK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catheter Precision Inc Insider Transactions
Mark E Saad Mailing Address
Above is the net worth, insider trading, and ownership report for Mark E Saad. You might contact Mark E Saad via mailing address: C/o Cytori Therapeutics, Inc., 3020 Callan Road, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
